BRCA2 and ovarian cancer: A substantial percentage of BRCA1/2 positive patients diagnosed after the age of 60 (n = 8/20) is consistent with the previous reports, indicating that the incidence of ovarian cancer in older age does not exclude BRCA germline mutation, especially as far as the BRCA2 gene is concerned (Brozek et al. 2012; Risch et al. 2001).